Overview
High-performance neurostimulator
The lntellis™ with AdaptiveStim™ rechargeable neurostimulator is powered by proprietary Overdrive™ battery technology. It is designed to overcome limitations with other SCS systems and is optimized for the increased energy demands of high energy waveforms.
- Small and thin fully implantable spinal cord neurostimulator.
- Designed for patient comfort and more flexible placement during the implant.
- ~1 hour recharge — empty to full.†
- 95% battery capacity at 9 years, independent of therapy parameters or recharge preferences.
- AdaptiveStim™ technology automatically adjusts the therapy as your patient moves, delivering a personalized treatment based on seven unique body positions.
- Snapshot™ reporting, powered by AdaptiveStim™ technology, allows physicians to objectively monitor a patient's progress.
DTM™ SCS waveform
DTM™ SCS is a proprietary programming approach inspired by science and rooted in pre-clinical research, and adapted to provide superior clinical outcomes.
The DTM™ SCS 12-month RCT proved sustained superiority compared to conventional stimulation.
- DTM™ SCS has an 84% back pain responder rate at 12-months.1
- DTM™ SCS has a 69% profound back pain response rate (≥80% pain relief) at 12 months.1
Unimpeded 1.5T full-body MRI access‡
- SureScan™ MRI technology allows MRI scans anywhere on the body, enabling diagnostic care.
- Shielded leads and proprietary device safeguards help patients safely get an MRI.
- Access matters — up to 98% of patients are expected to need at least one MRI within 10 years of implant.2
Creating new connections
The Medtronic adaptor extension creates a connection with certain Boston Scientific or Nevro leads. This enables patients with existing leads to gain access to superior DTM™ SCS therapy on Intellis™ INS.1 For patients wanting rapid recharge with Intellis™ INS or recharge-free convenience with Vanta™ INS, the adaptor extension allows you to offer meaningful pain relief with DTM™ SCS endurance waveform.3
Compatible products and features
Wireless External Neurostimulator
- Wireless, sterile single-use external neurostimulator simplifies testing during trial and implant.
- Designed for patient comfort and convenience.
| Model Number | 97725 |
|---|---|
| Weight | 71g (2.5oz) |
| Length | 79mm (3.1in) |
| Width | 74mm (2.9in) |
| Battery Type | Non-rechargeable |
| Thickness | 20mm (0.8in) |
Clinician Programmer
- Tablet with touchscreen interface
- Secure, wireless programming outside the sterile field
- Tailored programming workflows
- Electronic transfer of a variety of reports
- Bluetooth® communication
- Requires the use of the Intellis™ clinician programmer app and communicator device
Combined Patient Programmer and Recharger
- Recharge from fully depleted battery.
- Easy-to-adjust therapy.
- Easy-to-read interface.
- Large, pliable recharge antenna designed for patient comfort.
Compatible products
- 1x8 Vectris™ and Vectris™ SureScan™ MRI percutaneous leads and Injex™ anchoring system models 97791 and 97792.
- 16-electrode Specify™ SureScan™ MRI surgical leads.
Intellis™ with AdaptiveStim™ technology
| Model | 97715 |
|---|---|
| Channels | 2 |
| Volume | 13.9cc |
| Height | 57.1mm (2.2in) |
| Width | 47.2mm (1.9in) |
Manuals and technical guides
Access prescriber, implant, MRI, and other manuals on the Medtronic Manual Library. Search by the product name (Intellis™) or model number (97715). You may also call 800-961-9055 for a copy of a manual.
Contact us
U.S. clinician services
800-707-0933
*
© 2024 Medtronic. All rights reserved. Medtronic, Medtronic logo, and Engineering the extraordiary are trademarks of Medtronic. ®*Third-party brands are trademarks of their respective owners. All other brands are trademarks of a Medtronic company.
†
Under excellent coupling condition when recharging is set to the highest speed.
‡
Under specific conditions. Refer to product labeling for full list of conditions. Patients with non-Medtronic leads and an EMBSNV20 adaptor extension are not eligible for an MRI.
1
Fishman M, Cordner H, Justiz R, et al. 12-Month Results from multicenter, open-label, randomized controlled clinical trial comparing differential target multiplexed spinal cord stimulation and traditional spinal cord stimulation in subjects with chronic intractable back pain and leg pain. Pain Pract. 2021; 00: 1–12. doi: 10.1111/papr.13066.
2
Desai MJ, Hargens LM, Breitenfeldt MD, et al. The rate of magnetic resonance imaging in patients with spinal cord stimulation. Spine. 2015;40(9):E531–537.
3
Peacock, Provenzano, Fishman, et al. Long-Term Clinical Outcomes of a Low-Energy Derivative Study of Differential Target Multiplexed™️ Spinal Cord Stimulation. Poster presented at: North American Neuromodulation Society (NANS) 26th Annual Meeting; Jan 12-15, 2023; Las Vegas, NV.
The Bluetooth® word mark and logos are registered trademarks owned by Bluetooth SIG, Inc. and any use of such marks by Medtronic is under license.